Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjogren's syndrome mouse model
Open Access
- 1 June 2020
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 34 (6), 7733-7744
- https://doi.org/10.1096/fj.201902196R
Abstract
Our previous results showed that the specialized pro-resolving mediator (SPM) Resolvin D1 (RvD1) promotes resolution of inflammation in salivary glands in non-obese diabetic (NOD)/ShiLtJ, a mouse model for Sjogren's syndrome (SS). Additionally, mice lacking the RvD1 receptor ALX/FPR2 show defective innate and adaptive immune responses in salivary glands. Particularly, ALX/FPR2 KO mice exhibit exacerbated inflammation in their salivary glands in response to systemic LPS treatment. Moreover, female ALX/FPR2 KO mice show increased autoantibody production and loss of salivary gland function with age. Together, these studies suggest that an underlying SPM dysregulation could be contributing to SS progression. Therefore, we investigated whether SPM production is altered in NOD/ShiLtJ using metabololipidomics and enzyme-linked immunosorbent assay (ELISA). Our results demonstrate that SPM levels were broadly elevated in plasma collected from NOD/ShiLtJ female mice after disease onset, whereas these drastic changes did not occur in male mice. Moreover, gene expression of enzymes involved in SPM biosynthesis were altered in submandibular glands (SMG) from NOD/ShiLtJ female mice after disease onset, with 5-LOX and 12/15-LOX being downregulated and upregulated, respectively. Despite this dysregulation, the abundances of the SPM products of these enzymes (ie, RvD1 and RvD2) were unaltered in freshly isolated SMG cells suggesting that other cell populations (eg, lymphocytes) may be responsible for the overabundance of SPMs that we observed. The elevation of SPMs noted here appeared to be sex mediated, meaning that it was observed only in one sex (females). Given that SS primarily affects females (roughly 90% of diagnosed cases), these results may provide some insights into the mechanisms underlying the observed sexual dimorphism.Funding Information
- National Institute of Dental and Craniofacial Research (R01DE027884)
This publication has 69 references indexed in Scilit:
- Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formationAmerican Journal of Physiology-Cell Physiology, 2012
- Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the corneaThe FASEB Journal, 2011
- Metabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by PhagocytesCurrent Protocols in Immunology, 2011
- Resolvin D1 binds human phagocytes with evidence for proresolving receptorsProceedings of the National Academy of Sciences of the United States of America, 2010
- Anti-angiogenesis Effect of the Novel Anti-inflammatory and Pro-resolving Lipid MediatorsInvestigative Ophthalmology & Visual Science, 2009
- An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorptionBritish Journal of Pharmacology, 2008
- Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genusBritish Journal of Pharmacology, 2008
- Anti-Inflammatory and Proresolving Lipid MediatorsAnnual review of pathology, 2008
- Resolution of in flammation: state of the art, definitions and termsThe FASEB Journal, 2007
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005